CAS: 1862212-48-3
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
TH 1217 REF: IN-DA01LQLLCAS: 1862212-48-3 | 98% | To inquire | Tue 21 Jan 25 | |
TH1217 REF: TM-T38271CAS: 1862212-48-3 | 99.3% | To inquire | Tue 11 Mar 25 | |
TH 1217 REF: 3D-MZC21248CAS: 1862212-48-3 | Min. 95% | - - - | Discontinued product |
Ref: IN-DA01LQLL
5mg | 288.00 € | ||
10mg | 473.00 € | ||
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
TH1217
CAS:1862212-48-3
TH1217: potent dCTPase inhibitor, IC50=47 nM; boosts cytidine analogues in leukemia, may affect COVID-19.
Formula:
C20H17BCl2N4O6
Purity:
99.3%
Color and Shape:
Liquid
Molecular weight:
491.09
Ref: TM-T38271
1mg | 38.00 € | ||
5mg | 82.00 € | ||
10mg | 122.00 € | ||
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 11 Mar 2025
TH 1217
CAS:1862212-48-3
TH 1217 is a peptide that was originally isolated from human serum by affinity chromatography. …
Formula:
C20H17BCl2N4O6
Purity:
Min. 95%
Molecular weight:
491.1 g/mol
Ref: 3D-MZC21248
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |